Amyl Therapeutics is a preclinical-stage biotechnology company developing Pan-Amyloid Immunotherapy, a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases
Amyl Therapeutics is a preclinical-stage biotechnology company developing Pan-Amyloid Immunotherapy, a groundbreaking approach designed to become a universal treatment for neurodegenerative diseases.